Corcept Therapeutics (CORT) announced that the FDA has issued a complete response letter, or CRL, regarding the new drug application, or NDA, for relacorilant as a treatment for patients with ...

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 51.4% in the afternoon session after the U.S. Food and ...

Corcept Therapeutics stock falls after FDA rejects relacorilant for hypertension secondary to hypercortisolism; company to ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Corcept Therapeutics ( ($CORT) ) has shared an announcement. On December 31, 2025, Corcept Therapeutics announced that the U.S. Food and Drug ...

FDA rejects cortisol modulator for hypertension, citing need for additional data despite trial success, delaying approval for Corcept ...

A white ombré effect can help soften a classic French tip and give it a more modern feel. The pale gradient effect can also ...

One of the most critical studies on microbial ecology is to reveal microbial turnover patterns along spatial, temporal, or environmental gradients.

Relacorilant is an oral selective glucocorticoid receptor antagonist that has received orphan drug designation from both the FDA and European Commission for hypercortisolism treatment. The drug is ...

Octo Prints & Lighting announced the June 26, 2025 launch of its polycarbonate light panels, available in standard 2×2 and ...

After 30 years of glitchy swiping, it's finally time for New Yorkers to get the subway experience that they deserve.